Susquehanna International Group, LLP Alx Oncology Holdings Inc Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1.81 - $8.13 $171,226 - $769,098	-94,600 Reduced 90.1%	10,400 $18,000
Q2 2024 Aug 15, 2024	BUY	$5.84 - $17.56 $547,208 - $1.65 Million	93,700 Added 829.2%	105,000 $633,000
Q1 2024 May 07, 2024	SELL	$10.95 - $16.79 $466,469 - $715,254	-42,600 Reduced 79.04%	11,300 $125,000
Q4 2023 Feb 14, 2024	BUY	$4.81 - $15.38 $200,095 - $639,808	41,600 Added 338.21%	53,900 $802,000
Q3 2023 Nov 14, 2023	BUY	$4.19 - $7.35 $8,799 - $15,435	2,100 Added 20.59%	12,300 $59,000
Q2 2023 Aug 11, 2023	BUY	$4.37 - $9.56 $44,574 - $97,512	10,200 New	10,200 $76,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $72.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.